Toby Michael Maher

Cytowane przez

	Wszystkie	Od 2020
Cytowania	39278	27718
h-indeks	92	78
i10-indeks	291	263

7000

3500

1750

5250

2010201120122013201420152016201720182019202020212022202320242025136 189 244 405 708 1152 1391 1879 2124 2714 3744 5054 5058 5881 6592 1302

Dostęp publiczny

Wyświetl wszystko

224 artykuły

17 artykułów

dostępne

niedostępne

Objęte finansowaniem

Współautorzy

Athol U WellsProfessor of Respiratory Medicine, Imperial College,Zweryfikowany adres z rbht.nhs.uk
Philip L MolyneauxImperial CollegeZweryfikowany adres z imperial.ac.uk
Vincent CottinUniversity of LyonZweryfikowany adres z chu-lyon.fr
Michael KreuterMainz Center for pulmonary diseases, University of Mainz and Marienhaus Klinikum Mainz, GermanyZweryfikowany adres z marienhaus.de
Andrew G NicholsonHonorary Professor of Respiratory Pathology, Imperial College, LondonZweryfikowany adres z rbht.nhs.uk
Richard Gisli JenkinsMargaret Turner Warwick Chair of Thoracic Medicine Imperial College LondonZweryfikowany adres z imperial.ac.uk
Martin KolbProfessor of Medicine, McMaster University HamiltonZweryfikowany adres z mcmaster.ca
Davin Hansel 0057StudentZweryfikowany adres z mhs.mdp.ac.id
Costabel, UlrichRuhrlandklinik, University Medicine Essen, 45239 Essen, GermanyZweryfikowany adres z rlk.uk-essen.de
Tamera CorteUniversity of SydneyZweryfikowany adres z sydney.edu.au
Felix ChuaRespiratory Physician, Royal Brompton HospitalZweryfikowany adres z rbht.nhs.uk
Anne-Marie RussellProfessor College of Medicine and Dentistry University of BirminghamZweryfikowany adres z bham.ac.uk
Moisés SelmanInstituto Nacional de Enfermedades RespiratoriasZweryfikowany adres z iner.gob.mx
Bruno Crestaniuniversité paris diderotZweryfikowany adres z bch.aphp.fr
Peter M GeorgeRoyal Brompton and Harefield NHS Foundation TrustZweryfikowany adres z rbht.nhs.uk
Imre NothZweryfikowany adres z hscmail.mcc.virginia.edu
Pauline LukeyDirector, drug discovery and developmentZweryfikowany adres z target2treatment.com
Sujal DesaiProfessor of Practice (Thoracic Imaging), National Heart & Lung Institute, Imperial College LondonZweryfikowany adres z rbht.nhs.uk
Shervin AssassiThe University of Texas Health Science Center at HoustonZweryfikowany adres z uth.tmc.edu
Adam J ByrneImperial College LondonZweryfikowany adres z imperial.ac.uk

Obserwuj

Toby Michael Maher

Keck Medicine of University of Southern California

Zweryfikowany adres z usc.edu - Strona główna

Pulmonology


Tytuł Sortuj wg cytatów Sortuj wg roku Sortuj wg tytułu	Cytowane przez Cytowane przez	Rok
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ... New England Journal of Medicine 370 (22), 2071-2082, 2014	4777	2014
Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, L Richeldi, CC Thomson, Y Inoue, T Johkoh, ... American journal of respiratory and critical care medicine 205 (9), e18-e47, 2022	1759	2022
Nintedanib for systemic sclerosis–associated interstitial lung disease O Distler, KB Highland, M Gahlemann, A Azuma, A Fischer, MD Mayes, ... New England Journal of Medicine 380 (26), 2518-2528, 2019	1526	2019
Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report HR Collard, CJ Ryerson, TJ Corte, G Jenkins, Y Kondoh, DJ Lederer, ... American journal of respiratory and critical care medicine 194 (3), 265-275, 2016	1377	2016
Interstitial lung disease in systemic sclerosis: a simple staging system NSL Goh, SR Desai, S Veeraraghavan, DM Hansell, SJ Copley, ... American journal of respiratory and critical care medicine 177 (11), 1248-1254, 2008	1345	2008
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis TE Fingerlin, E Murphy, W Zhang, AL Peljto, KK Brown, MP Steele, ... Nature genetics 45 (6), 613-620, 2013	867	2013
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial TM Maher, TJ Corte, A Fischer, M Kreuter, DJ Lederer, M Molina-Molina, ... The lancet Respiratory medicine 8 (2), 147-157, 2020	600	2020
Pulmonary fibrosis secondary to COVID-19: a call to arms? P Spagnolo, E Balestro, S Aliberti, E Cocconcelli, D Biondini, ... The Lancet Respiratory Medicine 8 (8), 750-752, 2020	596	2020
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis PL Molyneaux, MJ Cox, SAG Willis-Owen, P Mallia, KE Russell, ... American journal of respiratory and critical care medicine 190 (8), 906-913, 2014	553	2014
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised … AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ... The lancet Respiratory medicine 8 (5), 453-460, 2020	510	2020
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? TM Maher, AU Wells, GJ Laurent European Respiratory Journal 30 (5), 835-839, 2007	431	2007
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development P Spagnolo, JA Kropski, MG Jones, JS Lee, G Rossi, T Karampitsakos, ... Pharmacology & therapeutics 222, 107798, 2021	415	2021
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes TL Reddy, M Tominaga, DM Hansell, J von der Thusen, D Rassl, ... European Respiratory Journal 40 (2), 377-385, 2012	405	2012
Global incidence and prevalence of idiopathic pulmonary fibrosis TM Maher, E Bendstrup, L Dron, J Langley, G Smith, JM Khalid, H Patel, ... Respiratory research 22, 1-10, 2021	401	2021
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury CJ Scotton, MA Krupiczojc, M Königshoff, PF Mercer, YCG Lee, ... The Journal of clinical investigation 119 (9), 2550-2563, 2009	392	2009
Short‐term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis NS Goh, RK Hoyles, CP Denton, DM Hansell, EA Renzoni, TM Maher, ... Arthritis & rheumatology 69 (8), 1670-1678, 2017	355	2017
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study RG Jenkins, JK Simpson, G Saini, JH Bentley, AM Russell, R Braybrooke, ... The lancet Respiratory medicine 3 (6), 462-472, 2015	336	2015
Pulmonary macrophages: a new therapeutic pathway in fibrosing lung disease? AJ Byrne, TM Maher, CM Lloyd Trends in molecular medicine 22 (4), 303-316, 2016	327	2016
PD-1 up-regulation on CD4⁺ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production LJ Celada, JA Kropski, JD Herazo-Maya, W Luo, A Creecy, AT Abad, ... Science translational medicine 10 (460), eaar8356, 2018	313	2018
Interstitial lung diseases M Wijsenbeek, A Suzuki, TM Maher The Lancet 400 (10354), 769-786, 2022	303	2022

Nie można teraz wykonać tej operacji. Spróbuj ponownie później.

Prace 1–20

Cytowania rocznie

Powielone cytowania

Scalone cytowania

Dodaj współautorówWspółautorzy

Obserwuj

Cytowane przez

Współautorzy